Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
CJC-1295/Ipamorelin: Contraindications & Drug Interactions
Safety information for CJC-1295/Ipamorelin including known contraindications, drug interactions, and important precautions.
Back to CJC-1295/Ipamorelin overviewContraindications
- active cancer or history of cancer (GH/IGF-1 may promote tumor growth)
- diabetes or insulin resistance (GH antagonizes insulin)
- pregnancy
- pituitary tumors
Drug Interactions (4 interactions)
Important: This table summarizes known and theoretical interactions. Always consult a healthcare provider before combining CJC-1295/Ipamorelin with any medication.
| Drug | Classification | Mechanism |
|---|---|---|
| Insulin/diabetes medications | Theoretical | GH antagonizes insulin action — may worsen glycemic control |
| GH/IGF-1 therapies | Theoretical | Additive GH effects — risk of GH excess |
| Glucocorticoids | Theoretical | May suppress GH response to secretagogues |
| Thyroid hormones | Theoretical | May affect GH/IGF-1 axis modulation |
Use our interactive Drug Interaction Checker for real-time lookup.